GADICKE ANSBERT - Insider Non-Derivative Transactions at TCR2 THERAPEUTICS INC. (TCRR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 1, 2023, GADICKE ANSBERT's relationship to TCR2 THERAPEUTICS INC. (TCRR) is Director,TenPercentOwner, and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TCRR insiders.

Data Source: SEC.
GADICKE ANSBERT - Insider Non-Derivative Transactions of TCRR Common Stock
GADICKE ANSBERT - Insider Non-Derivative Transactions at TCRR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 2, 2023 J -- (Common Stock) 3854963 0 0
Jun 2, 2023 J -- (Common Stock) 304001 0 0
Jun 2, 2023 J -- (Common Stock) 3370982 0 0
May 23, 2023 Sell -- (Common Stock) 70170 1.88 304001
May 23, 2023 X -- (Common Stock) 178269 0.74 374171